Limitations Despite the strengths of this retrospective cohort study, including its comprehensive five-year follow-up and detailed hormonal profiling, several limitations must be acknowledged
Remember, your genes work when they have to work to do
How can the same cellular pathways, proteins, and mutations lead to pathologies with vastly different clinical presentations
[DOI] [PMC free article] [PubMed] [Google Scholar] 136.Kennedy B.K., Berger S.L., Brunet A., Campisi J., Cuervo A.M., Epel E.S., Franceschi C., Lithgow G.J., Morimoto R.I., Pessin J.E., et al
NAC can have a strong sulfur-like odor that may be normal for the material, but changes in odor, color, moisture or caking should be assessed against the specification and stability data
From this point, the success rate for the investigational biologics increases at each clinical phase, with 17% at Phase I, 27% at Phase II, 58% at Phase III, and 82% at the registration phase